Literature DB >> 15799825

Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.

Madhuchhanda Roy1, Jane Reiland, Brian P Murry, Vladimir Chouljenko, Konstantin G Kousoulas, Dario Marchetti.   

Abstract

Cancer metastasis, is a frequent manifestation of malignant melanoma progression. Successful invasion into distant organs by tumor cells must include attachment to microvessel endothelial cells, and degradation of basement membranes and extracellular matrix (ECM). Heparan sulfate proteoglycans (HSPG) are essential and ubiquitous macromolecules associated with the cell surface and ECM of a wide range of cells and tissues. Heparanase (HPSE-1) is an ECM degradative enzyme, which degrades the heparan sulfate (HS) chains of HSPG at specific intrachain sites. To investigate effects of changes in heparanase gene expression in metastatic melanoma cells, we constructed adenoviral vectors containing the full-length human HPSE-1 cDNA in both sense (Ad-S/hep) and antisense orientations (Ad-AS/hep). We found increased HPSE-1 expression and activity in melanoma cell lines following Ad-S/hep infection by Western blot analyses and specific HPSE-1 activity assay. Conversely, HPSE-1 content was significantly inhibited following infection with Ad-AS/Hep. Importantly, HPSE-1 modulation by these adenoviral constructs correlated with invasive cellular properties in vitro and in vivo. Our results suggest that HPSE-1 not only contributes to the invasive phenotype of melanoma cells, but also that the Ad-AS/hep-mediated inhibition of its enzymatic activity can be efficacious in the prevention and treatment of melanoma metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799825      PMCID: PMC1501137          DOI: 10.1593/neo.04493

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  47 in total

Review 1.  Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

Authors:  R V Iozzo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.

Authors:  Norihiko Sasaki; Nobuaki Higashi; Tomohiro Taka; Motowo Nakajima; Tatsuro Irimura
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 3.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

4.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.

Authors:  D Marchetti
Journal:  J Cell Physiol       Date:  1997-09       Impact factor: 6.384

6.  Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice.

Authors:  M Ishikawa; J W Dennis; S Man; R S Kerbel
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

7.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 9.  Heparan sulfate proteoglycans in invasion and metastasis.

Authors:  R D Sanderson
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

Review 10.  Brain-metastatic melanoma: a neurotrophic perspective.

Authors:  Dario Marchetti; Yvonne Denkins; Jane Reiland; Andrea Greiter-Wilke; Jennifer Galjour; Brian Murry; Jason Blust; Madhuchhanda Roy
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

View more
  21 in total

1.  Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.

Authors:  Vy M Tran; Anna Wade; Andrew McKinney; Katharine Chen; Olle R Lindberg; Jane R Engler; Anders I Persson; Joanna J Phillips
Journal:  Mol Cancer Res       Date:  2017-08-04       Impact factor: 5.852

Review 2.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

3.  Targeted silencing of heparanase gene by small interfering RNA inhibits invasiveness and metastasis of osteosarcoma cells.

Authors:  Lei Fan; Qiang Wu; Xiaojuan Xing; Yudong Liu; Zengwu Shao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

4.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

5.  Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma.

Authors:  Amichay Meirovitz; Esther Hermano; Immanuel Lerner; Eyal Zcharia; Claudio Pisano; Tamar Peretz; Michael Elkin
Journal:  Cancer Res       Date:  2011-03-29       Impact factor: 12.701

6.  Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.

Authors:  Y Yang; C Gorzelanny; A T Bauer; N Halter; D Komljenovic; T Bäuerle; L Borsig; M Roblek; S W Schneider
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

Review 7.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

Review 8.  Versatile role of heparanase in inflammation.

Authors:  Rachel Goldberg; Amichay Meirovitz; Nir Hirshoren; Raanan Bulvik; Adi Binder; Ariel M Rubinstein; Michael Elkin
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

9.  Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.

Authors:  Lei Yan; Keqiang Yan; Wang Kun; Lin Xu; Qian Ma; Yueqing Tang; Wei Jiao; Gangli Gu; Yidon Fan; Zhonghua Xu
Journal:  Tumour Biol       Date:  2012-10-12

10.  Clinical significance of urine heparanase in bladder cancer progression.

Authors:  Itay Shafat; Dov Pode; Tamar Peretz; Neta Ilan; Israel Vlodavsky; Benjamin Nisman
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.